WCHOB Outpatient Clinics
140 Hodge Avenue
Buffalo, NY 14222
- (716) 878-7588
for Endocrine Patients
- (716) 878-7262
for Diabetes Patients
- (716) 888-3827 Fax
- Map & Directions
National and international impact for Type 1 Diabetes
Dr. Teresa Quattrin
Dr. Teresa Quattrin, MD is chief of the Division of Endocrinology/Diabetes at Women & Children's Hospital of Buffalo; chief of service, Pediatric Medicine for Kaleida Health; and professor of pediatrics at the University at Buffalo Jacobs School of Medicine and Biomedical Sciences.
The care of children with Type 1 and Type 2 diabetes is provided by a team of professionals using a state-of-the-art approach tailored to meet each patient's needs. The team includes nine Board Certified/ Eligible Pediatric Diabetologist-Endocrinologists, one nurse practitioner and certified diabetes educator (CDE), two nurse-CDEs, 1 nurse educator, two registered dietician-CDEs, and one social worker. Clinic appointments take place at WCHOB during five half day sessions, with dietary and diabetes education available. Patients are also seen outside of clinic for dietary counseling and diabetes education.
The division is involved in state of the art basic and clinical research focusing on insulin resistance/signaling and the treatment and prevention of Type 1 diabetes and overweight. Opportunities are available for patients interested in participating in research studies, led by the physicians with the assistance of experienced research personnel. Our center participates in TrialNet, a federally-funded grant aimed at screening and prevention of Type 1 diabetes in high risk individuals. For more than 20 years, the Diabetes Center has collaborated in nationwide efforts aimed at diabetes treatment and prevention
The Diabetes Center plays a key role in the Type 1 Diabetes Exchange, the largest registry for Type 1 diabetes in the United States. Through the Type 1 Diabetes Exchange, patients of the Diabetes Center participate in trials studying how well the pancreas is able to produce insulin and the quality of life of those with diabetes. Planned future trials include new drugs to improve diabetes control. In addition, Dr. Quattrin and her colleagues at the University at Buffalo are testing a novel, family-based weight-control program targeting preschoolers at risk of becoming overweight. With the support of a $2.55 million grant from the National Institutes of Health (NIH), Buffalo Healthy Tots is partnering with pediatric health care providers in Buffalo and Western New York to pioneer this novel approach, for pediatricians throughout the United States to prevent and treat obesity in young children. We also participate in trials to test new drugs to improve control in type 2 diabetes.
Community outreach - Serving the local community
The Center works in tandem with the University at Buffalo and other members of the community to bring improvements to Buffalo and Western New York through the study and treatment of diabetes. A prime example of such partnerships is the $1.5 million endowment established at Women & Children’s Hospital of Buffalo Diabetes Center by The Seneca Diabetes Foundation.
The Diabetes Center at WCHOB, accredited by the American Diabetes Association (ADA) for the Education Recognition Program, is a frontrunner in Western New York and beyond providing multidisciplinary care of youth with diabetes. Our team of physicians, CDEs, and dieticians provides comprehensive diabetes education to the families of youth with diabetes with a focus on diabetes self-management. Additionally, the Center participates in workshops to educate school nurses and other health care professionals who provide supportive care for children with diabetes with the goal to improve overall diabetes care.
National and international impact
TrialNet is an international study funded by multiple sources, including the National Institutes of Health. The focus of TrialNet is to develop interventions that will prevent or delay the onset of Type 1 diabetes targeting family members of those with Type 1 diabetes, who are at highest risk for developing the disease. The WCHOB Diabetes Center, through an affiliation with Columbia University, is one of twenty-two major affiliate clinical centers in the United States, Canada, Europe, Australia, and New Zealand comprising the TrialNet network.
“Being selected as a clinical site for this study and being so successful in identifying and screening individuals at high risk for Type 1 diabetes is a result of the long-term commitment to the community by the Diabetes Center at Women & Children’s Hospital of Buffalo,” said Cheryl Klass, RN, MBA, President, Women & Children’s Hospital of Buffalo.
“If diabetes can be delayed, even for a few years,” says Dr. Quattrin, “those at risk may be able to postpone the challenges of controlling their glucose levels and the development of serious complications,” which include eye and kidney damage.
A broader scope
In addition to its focus on the prevention and treatment of diabetes, the Division of Endocrinology/Diabetes at WCHOB provides comprehensive care to those affected by endocrine disorders, such as short stature, thyroid conditions, precocious puberty, adrenal disorders, and disorder of sexual development (DSD). The Endocrine Clinic has been providing patient centered care with a multidisciplinary team for individuals with DSD and their families for many years, which has now become the standard of care. It is the region’s only center certified as a Newborn Screening referral center for Congenital Hypothyroidism and Adrenal Hyperplasia. The center participates in multiple medical drug trials which provide opportunities to the community to be a part of latest research.